Apply now »

Vice President of Commercial - U.S. Generics, Biosimilars & 505(b)(2)

Date:  Apr 23, 2026
Location: 

Somerset, NJ, US

Company:  Lupin

Header

Job Description

As VP of Commercial, you’ll lead the strategic development, launch, and growth of Lupin’s U.S.

generics portfolio with a specialized focus on biosimilars and 505(b)(2) assets. This executive will

drive market expansion, ensure profitable product positioning, and build commercial excellence

across the organization. The VP/SVP will architect go-to-market strategies that enhance profitability,

deepen market penetration, and position Lupin as a category leader. This role demands a forward-

thinking enterprise builder who can translate deep market insight into cross-functional momentum.


Key Responsibilities:


Strategic Leadership:

· Own and execute commercial strategies for U.S. generics, biosimilars, and 505(b)(2) assets, ensuring

alignment with overall business objectives.

· Guide lifecycle management, pricing, and go-to-market planning for both pipeline and approved 505(b)(2)

and generics products.

· Lead business development assessments for potential licensing, partnerships, and portfolio acquisitions

within the 505(b)(2) and generics space.

Collaboration & Alignment:

· Partner with Regulatory, R&D, Manufacturing, and Supply Chain teams to ensure commercial alignment

and seamless execution of strategies for 505(b)(2) and generics products.

· Build strong relationships with wholesale distributors, pharmacy networks, GPOs, and payers to enhance

market access and product uptake.

Market Intelligence & Competitive Analysis:

· Monitor competitive intelligence, market trends, and reimbursement dynamics to inform strategic

decisions and maintain a competitive edge in the 505(b)(2) and generics market.

· Oversee forecasting and budgeting processes for key therapeutic assets within the 505(b)(2) and generics

portfolio.

Team Development & Leadership:

· Champion team development, culture building, and cross-functional collaboration to foster a high-

performing and innovative team focused on 505(b)(2) and generics products.

Qualification and Experience

12+ years of progressive commercial experience in generics, biosimilars, and/or 505(b)(2)

pharmaceuticals.
Deep understanding of the U.S. payer and provider landscape. · Ability to navigate regulatory nuances specific to generics and hybrid pathways. · Executive presence and a history of leading high-performing commercial teams. · Bachelor’s degree in Life Sciences or Business; MBA or equivalent preferred. Preferred Attributes: · Experience with digital marketing and data-driven decision-making. · Familiarity with 340B, 505B2, GPOs, and institutional customer segments. · Ability to navigate ambiguity and drive results in a competitive market.

· Demonstrated success in launching and optimizing performance for complex assets.

Competencies

Collaboration
Customer Centricity
Developing Talent
Innovation & Creativity
Process Excellence
Result Orientation
Stakeholder Management
Strategic Agility


Nearest Major Market: New Jersey

Apply now »